These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 26225474)
1. IL-35 Is Involved in the Pathogenesis of Guillain-Barré Syndrome Through Its Influence on the Function of CD4+ T Cells. Liu H; Zhang W; Tian FF; Kun A; Zhou WB; Xiao B; Li J Immunol Invest; 2015; 44(6):566-77. PubMed ID: 26225474 [TBL] [Abstract][Full Text] [Related]
2. Th17 helper cell and T-cell immunoglobulin and mucin domain 3 involvement in Guillain-Barré syndrome. Liang SL; Wang WZ; Huang S; Wang XK; Zhang S; Wu Y Immunopharmacol Immunotoxicol; 2012 Dec; 34(6):1039-46. PubMed ID: 22738814 [TBL] [Abstract][Full Text] [Related]
3. Abnormality of circulating CD4(+)CD25(+) regulatory T cell in patients with Guillain-Barré syndrome. Chi LJ; Wang HB; Zhang Y; Wang WZ J Neuroimmunol; 2007 Dec; 192(1-2):206-14. PubMed ID: 17997492 [TBL] [Abstract][Full Text] [Related]
4. T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. Csurhes PA; Sullivan AA; Green K; Pender MP; McCombe PA J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1431-9. PubMed ID: 16170091 [TBL] [Abstract][Full Text] [Related]
5. Are Th17 cells and their cytokines a therapeutic target in Guillain-Barré syndrome? Wu X; Wang J; Liu K; Zhu J; Zhang HL Expert Opin Ther Targets; 2016; 20(2):209-22. PubMed ID: 26357850 [TBL] [Abstract][Full Text] [Related]
6. Comprehensive cytokine profiling provides evidence for a multi-lineage Th responses in Guillain Barré Syndrome. Debnath M; Nagappa M; Talukdar PM; Subbanna M; Sundaravadivel P; Shivakumar V; Dutta D; Wahatule R; Sinha S; Bindu PS; Periyavan S; Umamaheswara Rao GS; Taly AB Cytokine; 2018 Oct; 110():58-62. PubMed ID: 29704819 [TBL] [Abstract][Full Text] [Related]
7. Intravenous immunoglobulin promotes the proliferation of CD4 Zhang G; Wang Q; Song Y; Cheng P; Xu R; Feng X; Li X J Neuroimmunol; 2019 Nov; 336():577042. PubMed ID: 31479869 [TBL] [Abstract][Full Text] [Related]
9. Increased circulating Th17 cell populations and elevated CSF osteopontin and IL-17 concentrations in patients with Guillain-Barré syndrome. Han RK; Cheng YF; Zhou SS; Guo H; He RD; Chi LJ; Zhang LM J Clin Immunol; 2014 Jan; 34(1):94-103. PubMed ID: 24217817 [TBL] [Abstract][Full Text] [Related]
10. Evidence of altered Th17 pathway signatures in the cerebrospinal fluid of patients with Guillain Barré Syndrome. Debnath M; Nagappa M; Dutta D; Talukdar PM; Subbanna M; Shivakumar V; Wahatule R; Sinha S; Bindu PS; Periyavan S; Umamaheswara Rao GS; Kumar MA; Taly AB J Clin Neurosci; 2020 May; 75():176-180. PubMed ID: 32217048 [TBL] [Abstract][Full Text] [Related]
11. Increased levels of activated T-cells and reduced levels of CD4/CD25+ cells in peripheral blood of Guillain-Barré syndrome patients compared to controls. Harness J; McCombe PA J Clin Neurosci; 2008 Sep; 15(9):1031-5. PubMed ID: 18653346 [TBL] [Abstract][Full Text] [Related]
12. [Expressive changes of CD4(+)T cell subset transcription factors in patients with aplastic anemia, myelodysplastic syndrome and acute myeloid leukemia and their clinical significances]. Feng XM; Xu HZ; Zhang JY; Yin DM; Liu MM; Sui XH Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):1038-42. PubMed ID: 25130824 [TBL] [Abstract][Full Text] [Related]
13. The effects of IVIg therapy on serum levels of neuropeptide Y and cytokines in Guillain-Barré syndrome. Li C; Luo T; Cheng Y; Liu S; Qiao L; Wu X; Liu K Neurol Sci; 2020 Feb; 41(2):295-303. PubMed ID: 31494821 [TBL] [Abstract][Full Text] [Related]
14. Circulating Th17, Th22, and Th1 cells are elevated in the Guillain-Barré syndrome and downregulated by IVIg treatments. Li S; Jin T; Zhang HL; Yu H; Meng F; Concha Quezada H; Zhu J Mediators Inflamm; 2014; 2014():740947. PubMed ID: 24899787 [TBL] [Abstract][Full Text] [Related]
15. Elevated levels of cerebrospinal fluid and plasma interleukin-37 in patients with Guillain-Barré syndrome. Li C; Zhao P; Sun X; Che Y; Jiang Y Mediators Inflamm; 2013; 2013():639712. PubMed ID: 24174711 [TBL] [Abstract][Full Text] [Related]
16. Elevated number of cells secreting transforming growth factor beta in Guillain-Barré syndrome. Dahle C; Kvarnstrom M; Ekerfelt C; Samuelsson M; Ernerudh J APMIS; 2003 Dec; 111(12):1095-104. PubMed ID: 14678018 [TBL] [Abstract][Full Text] [Related]
18. IL-10 and IFN-gamma in Guillain-Barré syndrome. Network Members of the Swedish Epidemiological Study Group. Press R; Deretzi G; Zou LP; Zhu J; Fredman P; Lycke J; Link H J Neuroimmunol; 2001 Jan; 112(1-2):129-38. PubMed ID: 11108941 [TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor 2 and -4 are involved in the pathogenesis of the Guillain-Barré syndrome. Du Y; Zhang G; Zhang Z; Wang Q; Ma R; Zhang L; Fan F; Li Y; Wang M; Lv H; Kang X Mol Med Rep; 2015 Aug; 12(2):3207-13. PubMed ID: 25954926 [TBL] [Abstract][Full Text] [Related]
20. Th17 pathway signatures in a large Indian cohort of Guillain Barré syndrome. Debnath M; Nagappa M; Subbanna M; Sundaravadivel P; Talukdar PM; Shivakumar V; Wahatule R; Dutta D; Binukumar B; Sinha S; Bindu PS; Periyavan S; Umamaheswara Rao GS; Taly AB J Neuroimmunol; 2018 Oct; 323():125-130. PubMed ID: 30196825 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]